Intro. to Computer

APA Research Paper (Mirano)

Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006). This paper follows the style guidelines in the Publication Manual of the American Psychological Association, 5th ed. (2001), and the APA Style Guide to Electronic References (2007).

Obesity in Children i

Can Medication Cure Obesity in Children?

A Review of the Literature

Luisa Mirano

Psychology 107, Section B

Professor Kang

October 31, 2004

Short title and page number for student papers. Lowercase roman numerals are used on title page and abstract page, arabic numerals on all text pages.

Full title, writer’s name, and section number of course, instructor’s name, and date (all cen- tered).

XXXX

Marginal annotations indicate APA-style formatting and effective writing.

Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).

Abstract appears on a separate page.

Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).

Full title, centered.

The writer uses a footnote to define an essential term that would be cum- bersome to define within the text.

The writer sets up her organiza- tion by posing four questions.

The writer states her thesis.

Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).

Headings, centered, help readers follow the organization.

In a signal phrase, the word “and” links the names of two authors; the date is given in parentheses.

Because the author (Carmona) is not named in the signal phrase, his name and the date appear in parenthe- ses, along with the paragraph number of the electronic source.

Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).

Ellipsis mark indicates omitted words.

An ampersand links the names of two authors in parentheses.

The writer draws attention to an important article.

Obesity in Children 4

Table 1 Effectiveness of Sibutramine and Orlistat in Adolescents

Average weight

Medication Subjects Treatmenta Side effects loss/gain

Sibutra- mine

Orlistat

Control

Medi- cated

Control

Medi- cated

0-6 mos.: placebo

6-12 mos.: sibutra- mine

0-12 mos.: sibutra- mine

0-12 mos.: placebo

0-12 mos.: orlistat

Mos. 6-12: increased blood pres- sure; in- creased pulse rate

Increased blood pres- sure; in- creased pulse rate

None

Oily spot- ting; flatu- lence; abdominal discomfort

After 6 mos.: loss of 3.2 kg (7 lb)

After 12 mos.: loss of 4.5 kg (9.9 lb)

After 6 mos.: loss of 7.8 kg (17.2 lb)

After 12 mos.: loss of 7.0 kg (15.4 lb)

Gain of 0.67 kg (1.5 lb)

Loss of 1.3 kg (2.9 lb)

Note. The data on sibutramine are adapted from “Behavior Therapy and Sibutramine for the Treatment of Adolescent Obesity,” by R. I. Berkowitz, T. A. Wadden, A. M. Tershakovec, & J. L. Cronquist, 2003, Journal of the American Medical Association, 289, pp. 1807-1809. The data on orlistat are adapted from Xenical (Orlistat) Capsules: Complete Product Informa- tion, by Roche Laboratories, December 2003, retrieved from http://www .rocheusa.com/products/xenical/pi.pdf aThe medication and/or placebo were combined with behavioral therapy in all groups over all time periods.

Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).

The writer uses a table to summa- rize the findings presented in two sources.

A note gives the source of the data.

A content note explains data common to all subjects.

Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).

When this article was first cited, all four authors were named. In subse- quent citations of a work with three to five authors, “et al.” is used after the first author’s name.

Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).

For a source with six or more authors, the first author’s surname followed by “et al.” is used for the first and subsequent references.

Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).

The writer develops the paper’s thesis.

Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).

Brackets indicate a word not in the original source.

A quotation longer than 40 words is set off from the text without quotation marks.

The writer inter- prets the evidence; she doesn’t just report it.

The tone of the conclusion is ob- jective.

Obesity in Children 9

While none of the medications currently available is a miracle

drug for curing the nation’s 9 million obese children, research

has illuminated some of the underlying factors that affect obe-

sity and has shown the need for a comprehensive approach to

the problem that includes behavioral, medical, social, and

political change.

Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).

Obesity in Children 10

References

Berkowitz, R. I., Wadden, T. A., Tershakovec, A. M., & Cron-

quist, J. L. (2003). Behavior therapy and sibutramine

for the treatment of adolescent obesity. Journal of the

American Medical Association, 289, 1805-1812.

Carmona, R. H. (2004, March 2). The growing epidemic of child-

hood obesity. Testimony before the Subcommittee on

Competition, Foreign Commerce, and Infrastructure of

the U.S. Senate Committee on Commerce, Science, and

Transportation. Retrieved from http://www.hhs.gov/asl

/testify/t040302.html

Critser, G. (2003). Fat land: How Americans became the fattest

people in the world. Boston: Houghton Mifflin.

Duenwald, M. (2004, January 6). Slim pickings: Looking

beyond ephedra. The New York Times, p. F1. Retrieved

from LexisNexis.

Henry J. Kaiser Family Foundation. (2004, February). The role

of media in childhood obesity. Retrieved from http://www

.kff.org/entmedia/7030.cfm

Hilts, P. J. (2002, March 20). Petition asks for removal of diet

drug from market. The New York Times, p. A26. Retrieved

from LexisNexis.

Hoppin, A. G., & Taveras, E. M. (2004, June 25). Assessment

and management of childhood and adolescent obesity.

Clinical Update. Retrieved from http://www.medscape

.com/viewarticle/481633

McDuffie, J. R., Calis, K. A., Uwaifo, G. I., Sebring, N. G.,

Fallon, E. M., Hubbard, V. S., et al. (2003). Three-

Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).

List of references begins on a new page. Heading is centered.

List is alphabet- ized by authors’ last names. All authors’ names are inverted.

The first line of an entry is at the left margin; subsequent lines indent 1⁄2'' (or five spaces).

Double-spacing is used throughout.

Obesity in Children 11

month tolerability of orlistat in adolescents with

obesity-related comorbid conditions. Obesity Research,

10, 642-650.

Roche Laboratories. (2003, December). Xenical (orlistat) cap-

sules: Complete product information. Retrieved from

http://www.rocheusa.com/products/xenical/pi.pdf

Yanovski, S. Z., & Yanovski, J. A. (2002). Drug therapy: Obesity.

The New England Journal of Medicine, 346, 591-602.

Source: Diana Hacker (Boston: Bedford/St. Martin’s, 2006).